Pharmaceutical analysis by supercritical fluid chromatography: Optimization of the mobile phase composition on a 2-ethylpyridine column

Journal of Separation Science

Volumn 31, Issue 8, 2008, Pages 1299-1306

  Brunelli, Claudio ^a   Zhao, Yining ^b   Brown, Melissa Hanna ^c   Sandra, Pat ^a  

^a GHENT UNIVERSITY   (Belgium)

^b PFIZER INC   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

2 Ethylpyridine stationary phase; Mobile phase optimization; Pharmaceuticals; Supercritical fluid chromatography

Indexed keywords

CHEMICAL PROPERTIES; DRUG PRODUCTS; OPTIMIZATION; PHASE COMPOSITION; PHYSICAL PROPERTIES; SUPERCRITICAL FLUIDS;

ETHYLPYRIDINE COLUMN; MOBILE PHASE COMPOSITION; PHARMACEUTICAL ANALYSIS; SUPERCRITICAL FLUID CHROMATOGRAPHY;

LIQUID CHROMATOGRAPHY;

2 ETHYLPYRIDINE; CORTISONE; ESTRADIOL; ESTRIOL; ESTRONE; FLURBIPROFEN; FORMIC ACID; HYDROCORTISONE; IBUPROFEN; KETOPROFEN; METHANOL; METHYLTESTOSTERONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROGESTERONE; PURINE DERIVATIVE; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; SILICA GEL; STEROID; SULFADIMETHOXINE; SULFAGUANIDINE; SULFAMERAZINE; SULFAMETHIZOLE; SULFAMETHOXAZOLE; SULFAQUINOXALINE; SULFONAMIDE; TESTOSTERONE; UNINDEXED DRUG; XANTHINE DERIVATIVE;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SEPARATION TECHNIQUE; SUPERCRITICAL FLUID CHROMATOGRAPHY;

CHEMISTRY, ANALYTICAL; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, SUPERCRITICAL FLUID; FORMIC ACIDS; LABORATORY TECHNIQUES AND PROCEDURES; METHANOL; MODELS, CHEMICAL; PHARMACEUTICAL PREPARATIONS; PROPYLAMINES; PYRIDINES; STEROIDS; TECHNOLOGY, PHARMACEUTICAL;

EID: 44349084747     PISSN: 16159306     EISSN: 16159314     Source Type: Journal    
DOI: 10.1002/jssc.200700555     Document Type: Article

References (16)

1. Ibañez, E., Li, M., Malik, M., Lee, M. L., J. High Resolut. Chromatogr. 1999, 18, 559-563.
2. Cantrell, G. O., Stringham, R. W., Blackwell, J., Anal Chem. 1996. 68, 3645-3650.
3. Berger, T. A., J. Chromatogr. A 1997, 785, 3-33 and references cited.
4. West, C., Lesellier, E., J. Chromatogr. A 2005, 1087, 64-76.
5. Zou, W., Dorsey, J. G., Chester, T., Anal. Chem. 2000, 72, 3620-3626.
6. Billie, A. L., Greibrokk, T., Anal. Chem. 1985, 57, 2239-2242.
7. Berger, T. A., Deye, J. F., Anal. Chem. 1990, 62, 1181-1185.
8. Berger, T. A., Deye, J. F., J. Chromatogr. 1991, 547, 377-392.
9. Berger, T. A., Deye, J. F., J. Chromatogr. Sci. 1991, 29, 310-317.
10. Ibañez, E., Señoráns, F. J., J. Biochem. Biophys. Methods 2000, 43, 25-43.
11. Farrell, W. P., Abstracts of Papers, 226th ACS National Meeting, New York, NY, US, September 7-11, 2003.
12. Bolanos, B., Greig, M., Ventura, M., Farrell, W. P., Aurigemma, C., Li, H., Quenzer, T. L., Tivel, K., Bylund, J., Tran, P., Pham, C., Phillipson, D., Int. J. Mass Spectrom. 2004, 238, 85-97.
13. White Craig, C., Burnett, J., J. Chromatogr. A 2005, 1074, 175-185.
14. Zhao, Y., Semin, D., in: Lee. M. (Ed.). Integrated Strategies for Drug Discovery Using Mass Spectrometry, John Wiley & Sons, New York, USA 2005, Chapter 14, p. 421.
15. Zhao, Y., Sandra, P., Woo, G., Thomas, S., Gahm, K., Semin, D., Pharm. Discov. 2005, 5, 30-41.
16. Zheng, J., Pinkston, J. D., Zoutendam, P. H., Taylor, L. T., Anal. Chem. 2006, 78, 1535-1545.